Value Drug Company v. Takeda Pharmaceuticals, U.S.A., Inc
Value Drug Company v. Takeda Pharmaceuticals, U.S.A., Inc is a federal antitrust lawsuit filed on 12/05/2022 in the District Court, E.D. Pennsylvania. The case was terminated on 12/05/2022.
- Court
- District Court, E.D. Pennsylvania (E.D. Pa.)
Official Court Website → - Assigned judge
- Mark A. Kearney · 873 cases in index
- Docket number
- 2:22-mc-00066
- Cause
- 15:1 Antitrust Litigation
15 U.S.C. § 1 — Sherman Antitrust Act - Nature of suit
- 410 Other Statutes: Anti-Trust
Claims of unlawful restraint of trade, monopolization, or anticompetitive conduct under the Sherman and Clayton Acts. - Jurisdiction
- Federal Question
- Jury demand
- None
- Date filed
- 12/05/2022
- Date terminated
- 12/05/2022
1,619 Antitrust cases in this court are indexed here.
Parties
- plaintiff · Value Drug Company · 20 cases
- defendant · Takeda Pharmaceuticals U S A Inc · 3175 cases
Part of a Larger Litigation Pattern
This is one of 3,176 Antitrust cases in our index naming Takeda Pharmaceuticals U S A Inc — a possible mass-tort or coordinated-litigation cluster.
About Antitrust Lawsuits
Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.
Frequently Asked Questions
What is Value Drug Company v. Takeda Pharmaceuticals, U.S.A., Inc?
Value Drug Company v. Takeda Pharmaceuticals, U.S.A., Inc is a federal antitrust lawsuit filed on 12/05/2022 in the District Court, E.D. Pennsylvania. The case was terminated on 12/05/2022. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.
What type of case is this?
It is classified as “Antitrust” under the federal nature-of-suit system. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.
What court is the case in?
The case is in the District Court, E.D. Pennsylvania, docket number 2:22-mc-00066.
When was the case filed?
Value Drug Company v. Takeda Pharmaceuticals, U.S.A., Inc was filed on 12/05/2022. It was terminated on 12/05/2022.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 1 — Sherman Antitrust Act.
Other Cases Involving These Parties
Related Antitrust Cases
Source: public U.S. federal court record (docket 66612107).